APA

El-Awady M. K., El Gendy M., Waked I., Tabll A. A., El Abd Y., Bader El Din N., El Shenawy R., Allam A., Abdelhafez T. H. & Dawood R. M. (2013). WITHDRAWN: Immunogenicity and safety of HCV E1E2 peptide vaccine in chronically HCV-infected patients who did not respond to interferon based therapy. : Vaccine.

Chicago

El-Awady Mostafa K, El Gendy Mohamed, Waked Imam, Tabll Ashraf A, El Abd Yasmin, Bader El Din Noha, El Shenawy Reem, Allam Aleef, Abdelhafez Tawfeek H and Dawood Reham M. 2013. WITHDRAWN: Immunogenicity and safety of HCV E1E2 peptide vaccine in chronically HCV-infected patients who did not respond to interferon based therapy. : Vaccine.

Harvard

El-Awady M. K., El Gendy M., Waked I., Tabll A. A., El Abd Y., Bader El Din N., El Shenawy R., Allam A., Abdelhafez T. H. and Dawood R. M. (2013). WITHDRAWN: Immunogenicity and safety of HCV E1E2 peptide vaccine in chronically HCV-infected patients who did not respond to interferon based therapy. : Vaccine.

MLA

El-Awady Mostafa K, El Gendy Mohamed, Waked Imam, Tabll Ashraf A, El Abd Yasmin, Bader El Din Noha, El Shenawy Reem, Allam Aleef, Abdelhafez Tawfeek H and Dawood Reham M. WITHDRAWN: Immunogenicity and safety of HCV E1E2 peptide vaccine in chronically HCV-infected patients who did not respond to interferon based therapy. : Vaccine. 2013.